MedCity News July 26, 2022
Decentralized and hybrid clinical trials have a faster enrollment rate and a higher retention rate than centralized models, research shows.
Covid-19 created a shift in the delivery of clinical trials, allowing for participants to access trials outside of a traditional research site, thus expanding the scope of clinical trials.
That was the message shared by Claudia Lucchinetti, director of Mayo Clinic Center for Clinical and Translational research, Tuesday at the Mayo Clinic Platform Conference.
At the conference, Lucchinetti discussed the transformation to decentralized clinical trials, which is a clinical trial that is completely conducted virtually through telehealth technology. This compares to a fully centralized clinical trial model, where the trial is conducted at an academic medical center or large community-based...
Today's Sponsors
Today's Sponsor